Proof of Concept
Chinastar has been using the equipment to produce what is the first (and only?) commercial IJP display product, a 21.6” display for the medical industry. Most recently Chinastar has shown both small (6.5”) and larger (14”) IJP displays and is now expected to begin offering 14” and 16” IJP notebook panels sometime in 1H 2026. Chinastar’s IJP line is rather small but given the relatively small size of the current display, the line has a maximum production level of 240,000 units/month (100% yield), likely far in excess of what Chinastar is able to sell, so capacity is not a current issue. That said, panel producers must look years into the future to decide whether to build out capacity and Chinastar is considering building a Gen 8.5 ink-jet fab to fill future demand.
There would be two key advantages to such a project. First, the Gen 5.5 fab currently being used (21.6” product) is rather inefficient, wasting 23% of the substrate with each production sheet. A Gen 8.5 IJP fab would bring that substrate efficiency up to ~93%, a substantial savings during high volume production. The Gen 5.5 fab can produce a maximum of ~240,000 21.6” displays each month (theoretical), while the Gen 8.5 IJP fab could produce ~800,000, so if Chinastar believes that IJP is enough of a differentiator to attract high volume customers, the Gen 8.6 fab would be needed.
It’s a tough decision given the importance of not only reducing the cost of production, but also exceeding the specs of competitive displays produced on more traditional deposition systems. If IJP is only an advantage for the producer, it’s a much harder sell than if it benefits both the producer and the customer, so there is still a lot for Chinastar to prove before they get enough customer feedback to justify spending a few billion on a new IJP fab.